In the realm of diagnostic innovation, the single-use probes and sensors market stands as a beacon of efficiency and adaptability. Redefining diagnostic procedures, these disposable technologies offer a seamless blend of precision and convenience. As the market surges forward, the emphasis on single-use solutions not only streamlines processes but also contributes to heightened hygiene standards. With a commitment to advancing healthcare practices, the Single-Use Probes and Sensors Market signifies a pivotal shift towards more accessible, reliable, and forward-looking diagnostic tools.
By the end of 2022, the single-use bioprocessing probes and sensors market is projected to have grown from its US$ 2.4 billion valuation in 2021 to US$ 2.7 billion. By the end of 2032, the global market is anticipated to be valued US$ 9.8 billion, growing at a compound annual growth rate (CAGR) of 13.8%. Between 2022 and 2032, the worldwide market will have an absolute monetary potential of US$ 7.1 billion. Single-use bioprocessing probes and sensors are growing in popularity due to enhanced demand for biopharmaceuticals and increased use of disposable systems in pre-clinical phases.
Continuous technological advancements and the increased use of machine learning, automation, and big data solutions in several applications is likely to boost the market growth. These analytical models aid in the prediction of errors and the improvement of medical procedure accuracy. Furthermore, the market is expected to grow due to development in supply chain facilities that use cost and time effective technology.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14802
pH Sensors are the most important segment in terms of Sensor type categorization, and they are predicted to remain competitive with a CAGR of 16.5% over the forecasted period. Rising product penetration and usage rates are responsible for a large amount of category growth. Furthermore, the Upstream segments dominate the workflow categorization and are predicted to increase at a CAGR of 13.9% throughout the forecasted period. This occurred as a result of the growing use of single-use bioreactors and media bags in the upstream manufacturing process.
Key Takeaways from the Market Study:
- Global Single-use Bioprocessing Probes and Sensors Market is expected to reach the valuation of US$ 9.8 Billion by 2032.
- The global market is expected to grow at a CAGR of 8% as compared to historical growth of just 11.4%.
- During the period between 2022 and 2032, the market is expected to offer an absolute dollar opportunity of US$ 7.1 Billion.
- The pH Sensors segment dominates the global market and is likely to grow at a CAGR of 5%.
- Among the Workflow types, Upstream workflow dominates the segment with the expected CAGR of 9% during the forecasted period.
- The U.S. market contributes significantly in the global market with around 29% Revenue through this segment is expected to grow at a CAGR of 12% during the forecasted period.
Continuous technological advancements and the increased use of Machine Learning, AI, Automation, and big data solutions in a number of applications are expected to boost the global market. These analytical models aid in the prediction of errors and the improvement of medical procedure accuracy, comments a Future Market Insights analyst.
Competitive Landscape:
Market players in single-use bioprocessing probes and sensors are pursuing numerous strategic initiatives such as OEM alliances, market expansion, and new product development with improved technological complexity to promote their organic revenue growth and market presence. They are developing partnerships with key OEMs to build their single-use plants.
Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-question/rep-gb-14802
The key developments in Global Single-use Bioprocessing Probes and Sensors Market are:
- In September 2020, Thermo Fisher Scientific inaugurated the new Bioprocessing Collaboration center in St. Louis to accelerate innovation and enhancing productivity of Biopharma companies.
- In November 2021, Sartorius AG announced that it will expand its operation, production, innovation and storage facilities in France by investing 100 Million Euros by 2025.
- In March 2022, ABEC collaborated with EKF Life Science for expanding its Biomanufacturing operations in U.S. market.
More Insights Available:
Future Market Insights, in its new offering, presents an unbiased analysis of the Single-use Bioprocessing Probes and Sensors market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights on the basis of Sensor Type (pH Sensor, Oxygen Sensor, Pressure Sensors, Temperature Sensors, Conductivity Sensors, Flow Meters & Sensors, Other Sensor Types), Workflow (Upstream & Downstream), End-use (Biopharmaceutical Manufacturer, Labs & Academic/ Clinical Research Institutes) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
Key Companies Profiled
- Sartorius AG
- Thermo Fisher Scientific
- Danaher Corporation
- PreSens Precision Sensing GmbH
- ABEC
- Hamilton Company
- PendoTECH LLC
- Equflow
- Parker Hannifin Corporation
- Malema Engineering Corporation
- Dover Corporation
Unleash Potential: Craft Your Customized Report Now:https://www.futuremarketinsights.com/customization-available/rep-gb-14802
Market Segments Covered in Single-use Bioprocessing Probes and Sensors Market Analysis
By Sensor Type:
- pH Sensor
- Oxygen Sensor
- Pressure Sensors
- Temperature Sensors
- Conductivity Sensors
- Flow Meters & Sensors
- Other Sensor Types
By Workflow:
- Upstream
- Downstream
By End Use:
- Biopharmaceutical Manufacturer
- Labs & Academic/ Clinical Research Institutes
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube